Abattis Bioceuticals Stock Price, News & Analysis
Company Description
Abattis Bioceuticals (OTC Link: ATTBF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $4.7M.
ATTBF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of ATTBF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Abattis Bioceuticals (ATTBF) stock last traded at $0.0000. At a market capitalization of $4.7M, ATTBF is classified as a micro-cap stock with approximately 477.8M shares outstanding.
Latest News
Abattis Bioceuticals has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all ATTBF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ATTBF Company Profile & Sector Positioning
Abattis Bioceuticals (ATTBF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ATTBF often look at related companies in the same sector, including TREES CORP (CANN), Valeo Pharma (VPHIF), Sunniva (SNNVF), Filament Health (FLHLF), and Delivra Health (DHBUF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATTBF's relative position within its industry.